Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +1.14% | +6.31% | +113.25% |
May. 30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.25% | 337M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- HC Wainwright Raises Price Target on ADC Therapeutics to $9 From $3, Maintains Buy Rating